Defu Zeng

5.4k total citations · 1 hit paper
94 papers, 4.3k citations indexed

About

Defu Zeng is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Defu Zeng has authored 94 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Immunology, 41 papers in Hematology and 20 papers in Oncology. Recurrent topics in Defu Zeng's work include T-cell and B-cell Immunology (51 papers), Immune Cell Function and Interaction (45 papers) and Hematopoietic Stem Cell Transplantation (40 papers). Defu Zeng is often cited by papers focused on T-cell and B-cell Immunology (51 papers), Immune Cell Function and Interaction (45 papers) and Hematopoietic Stem Cell Transplantation (40 papers). Defu Zeng collaborates with scholars based in United States, China and Australia. Defu Zeng's co-authors include Samuel Strober, Tangsheng Yi, Sussan Dejbakhsh‐Jones, Stephen J. Forman, Иван Тодоров, Hua Yu, Lin Wang, Drew M. Pardoll, Marcin Kortylewski and Fengshuo Lan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Defu Zeng

91 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway

2009 675 citations Tangsheng Yi, Marcin Kortylewski et al. profile →

Peers

Countries citing papers authored by Defu Zeng

Since Specialization

Citations

This map shows the geographic impact of Defu Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Defu Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Defu Zeng more than expected).

Fields of papers citing papers by Defu Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Defu Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Defu Zeng. The network helps show where Defu Zeng may publish in the future.

Co-authorship network of co-authors of Defu Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Defu Zeng. A scholar is included among the top collaborators of Defu Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Defu Zeng. Defu Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Progress in clinical research on allogeneic hematopoietic stem cell transplantation for the treatment of paroxysmal nocturnal hemoglobinuria 2025 ·(unknown), Defu Zeng, Rong Fu, Xiaohui Zhang	0
2	Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major histocompatibility complex class II are not required for inducing chimerism 2023 ·American Journal of Transplantation ·(unknown), Xiwei Wu, Shanshan Tang, Huiqing Wu, (unknown), Qi Qin, Qingxiao Song, (unknown), (unknown), Anita S. Chong, Arthur D. Riggs, Defu Zeng	2
3	Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD 2022 ·Blood Advances ·Nataliya P. Buxbaum, Gèrard Socié, Geoffrey R. Hill, Kelli P. A. MacDonald, Victor Tkachev, Takanori Teshima, Stephanie J. Lee, Jerome Ritz, Stefanie Sarantopoulos, Leo Luznik, Defu Zeng, Sophie Paczesny, Paul J. Martin, Steven Z. Pavletic, Kirk R. Schultz, Bruce R. Blazar	11
4	Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity 2022 ·Frontiers in Immunology ·Qingxiao Song, (unknown), Ryotaro Nakamura, Paul J. Martin, Defu Zeng	2
5	Th17 Cell-Derived Amphiregulin Promotes Colitis-Associated Intestinal Fibrosis Through Activation of mTOR and MEK in Intestinal Myofibroblasts 2022 ·Gastroenterology ·Xiaojing Zhao, Wenjing Yang, Tianming Yu, Yu Yu, Xiufang Cui, Zheng Zhou, Hui Yang, Yanbo Yu, Anthony J. Bilotta, Suxia Yao, Jimin Xu, Jia Zhou, Gregory S. Yochum, Walter A. Koltun, (unknown), Defu Zeng, Jingwu Xie, Iryna V. Pinchuk, Hongjie Zhang, Yingzi Cong	61
6	IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice 2021 ·Nature Communications ·Qingxiao Song, Xiaoning Wang, Xiwei Wu, (unknown), Hanjun Qin, Dongchang Zhao, Robert R. Jenq, Marcel R.M. van den Brink, Arthur D. Riggs, Paul J. Martin, (unknown), Defu Zeng	15
7	Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host disease–associated autoimmunity 2020 ·Journal of Clinical Investigation ·Xiaohui Kong, (unknown), Xiwei Wu, (unknown), Shijie Yang, Qingxiao Song, Yongping Zhu, Martha Salas, Hanjun Qin, (unknown), Karen M. Haas, Arthur D. Riggs, Ryotaro Nakamura, Paul J. Martin, Aimin Huang, Defu Zeng	24
8	Haploidentical mixed chimerism cures autoimmunity in established type 1 diabetic mice 2020 ·Journal of Clinical Investigation ·Yuqing Liu, Xiaoqi Wang, Yongping Zhu, Mingfeng Zhang, (unknown), (unknown), Stephen J. Forman, Arthur D. Riggs, Xi Zhang, Defu Zeng	5
9	Inhibition of Survival Signaling in B-Cell Lymphoma Using TLR9-Targeted Delivery of NF-Kb Decoy Oligodeoxynucleotides in Vitro and in Vivo 2018 ·Experimental Hematology ·Zhuoran Zhang, Dayson Moreira, Yu‐Lin Su, Piotr Swiderski, Defu Zeng, Marcin Kortylewski	1
10	Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80 2018 ·Frontiers in Immunology ·Kaniel Cassady, Paul J. Martin, Defu Zeng	31
11	Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease 2017 ·Nature Communications ·Ruishu Deng, Christian Hurtz, Qingxiao Song, Chanyu Yue, Gang Xiao, Hua Yu, Xiwei Wu, Markus Müschen, Stephen J. Forman, Paul J. Martin, Defu Zeng	51
12	Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease 2009 ·Blood ·Tangsheng Yi, Ying Chen, Lin Wang, (unknown), Daniel Q. Huang, Dongchang Zhao, Heather F Johnston, James S. Young, Иван Тодоров, Dale T. Umetsu, Lieping Chen, Yoichiro Iwakura, Fouad Kandeel, Stephen J. Forman, Defu Zeng	222
13	Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft versus host disease (141.13) 2009 ·The Journal of Immunology ·Tangsheng Yi, Ying Chen, Lin Wang, (unknown), Daniel Huang, Dongchang Zhao, James S. Young, Иван Тодоров, (unknown), Yoichiro Iwakura, (unknown), Defu Zeng	13
14	Elimination of insulitis and augmentation of islet β cell regeneration via induction of chimerism in overtly diabetic NOD mice 2007 ·Proceedings of the National Academy of Sciences ·Chunyan Zhang, Иван Тодоров, Chia-Lei Lin, Mark A. Atkinson, Fouad Kandeel, Stephen J. Forman, Defu Zeng	40
15	Donor CD8+ T Cells Mediate Graft-versus-Leukemia Activity without Clinical Signs of Graft-versus-Host Disease in Recipients Conditioned with Anti-CD3 Monoclonal Antibody 2007 ·The Journal of Immunology ·Chunyan Zhang, (unknown), (unknown), Иван Тодоров, Chia-Lei Lin, Yuan Cao, Christopher H. Contag, Fouad Kandeel, Stephen J. Forman, Defu Zeng	23
16	Characterization of novel antigens recognized by serum autoantibodies from anti‐CD1 TCR‐transgenic lupus mice 2004 ·European Journal of Immunology ·Wolfgang Hueber, Defu Zeng, Orr Sharpe, William H. Robinson, (unknown), (unknown)	4
17	Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus 2003 ·Journal of Clinical Investigation ·Defu Zeng, Yinping Liu, Stéphane Sidobre, Mitchell Kronenberg, Samuel Strober	120
18	Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus 2003 ·Journal of Clinical Investigation ·Defu Zeng, Yinping Liu, Stéphane Sidobre, Mitchell Kronenberg, Samuel Strober	112
19	Predominance of NK1.1+TCRαβ+ or DX5+TCRαβ+ T Cells in Mice Conditioned with Fractionated Lymphoid Irradiation Protects Against Graft-Versus-Host Disease: “Natural Suppressor” Cells 2001 ·The Journal of Immunology ·Fengshuo Lan, Defu Zeng, Masanori Higuchi, Philip Huie, Julian P. T. Higgins, Samuel Strober	132
20	Donor cells that facilitate tolerance to rat heart allografts after posttransplant total lymphoid irradiation and rabbit anti-thymocyte globulin 1999 ·Transplantation Proceedings ·(unknown), Defu Zeng, Samuel Strober	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact